Camrelizumab Combined with Gemcitabine and Albumin-Bound Paclitaxel in Pancreatic Cancer Patients with Liver Metastases: A Prospective, Pilot Trial
Drug Design, Development and Therapy · 2026
DOI: 10.2147/dddt.s568812 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Jiandong Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Deoxycytidine, Liver Neoplasms, Pancreatic Neoplasms, Antibodies, Monoclonal, Humanized. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
- Department of Intensive Care Unit, Sir Run Run Shaw Hospital Qiantang Campus, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
ORCID-Profile: Yizhuo Zhang
Zitieren
APA
Zhang, J., Zhao, K., Zhou, W., Jiang, G., Ding, Y., Zhang, Y., Dong, X., Hong, D., & Liu, X. (2026). Camrelizumab Combined with Gemcitabine and Albumin-Bound Paclitaxel in Pancreatic Cancer Patients with Liver Metastases: A Prospective, Pilot Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s568812
Vancouver
Zhang J, Zhao K, Zhou W, Jiang G, Ding Y, Zhang Y, et al. Camrelizumab Combined with Gemcitabine and Albumin-Bound Paclitaxel in Pancreatic Cancer Patients with Liver Metastases: A Prospective, Pilot Trial. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s568812
BibTeX
@article{Zhang2026,
author = {Zhang, Jiandong and Zhao, Kai and Zhou, Weihang and Jiang, Guixing and Ding, Ying and Zhang, Yizhuo and Dong, Xinyu and Hong, Defei and Liu, Xiaolong},
title = {Camrelizumab Combined with Gemcitabine and Albumin-Bound Paclitaxel in Pancreatic Cancer Patients with Liver Metastases: A Prospective, Pilot Trial},
journal = {Drug Design, Development and Therapy},
year = {2026},
doi = {10.2147/dddt.s568812}
}
EUVIMED